Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi(Délégation Paris 5), Federico Pietrocola(Inserm), José Manuel Bravo‐San Pedro(Inserm), Ravi K. Amaravadi(University of Pennsylvania), Eric H. Baehrecke(University of Massachusetts Chan Medical School), Francesco Cecconi(University of Rome Tor Vergata), Patrice Codogno(Délégation Paris 5), Jayanta Debnath(University of California, San Francisco), David A. Gewirtz(Virginia Commonwealth University), Vassiliki Karantza(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alec Kimmelman(Dana-Farber Cancer Institute), Sharad Kumar(University of South Australia), Beth Levine(Howard Hughes Medical Institute), Maria Chiara Maiuri(Inserm), Séamus J. Martin(Trinity College Dublin), Josef Penninger(Institute of Molecular Biotechnology), Mauro Piacentini(University of Rome Tor Vergata), David C. Rubinsztein(University of Cambridge), Hans‐Uwe Simon(University of Bern), Anne Simonsen(University of Oslo), Andrew Thorburn(University of Colorado Denver), Guillermo Velasco(Universidad Complutense de Madrid), Kevin M. Ryan(Cancer Research UK Scotland Institute), Guido Kroemer(Délégation Paris 5)
Cited by 1,156Open Access
Abstract
Related Papers
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis